Global Insulin Market Growth 2025-2031

Publication ID:

LPI07254956

Publication Date:

July 4, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Insulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.
The 鈥淚nsulin Industry Forecast鈥� looks at past sales and reviews total world Insulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Insulin sales for 2025 through 2031. With Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insulin industry.
This Insight Report provides a comprehensive analysis of the global Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Animal Insulin
Regular Human Insulin
Insulin Analogue
Segmentation by Application:
Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Key Questions Addressed in this Report
What is the 10-year outlook for the global Insulin market?
What factors are driving Insulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Insulin market opportunities vary by end market size?
How does Insulin break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Insulin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Insulin by Country/Region, 2020, 2024 & 2031
2.2 Insulin Segment by Type
2.2.1 Animal Insulin
2.2.2 Regular Human Insulin
2.2.3 Insulin Analogue
2.3 Insulin Sales by Type
2.3.1 Global Insulin Sales Market Share by Type (2020-2025)
2.3.2 Global Insulin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Insulin Sale Price by Type (2020-2025)
2.4 Insulin Segment by Application
2.4.1 Short Acting
2.4.2 Intermediate Acting
2.4.3 Long Acting
2.4.4 Pre-Mix Insulin
2.5 Insulin Sales by Application
2.5.1 Global Insulin Sale Market Share by Application (2020-2025)
2.5.2 Global Insulin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Insulin Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Insulin Breakdown Data by Company
3.1.1 Global Insulin Annual Sales by Company (2020-2025)
3.1.2 Global Insulin Sales Market Share by Company (2020-2025)
3.2 Global Insulin Annual Revenue by Company (2020-2025)
3.2.1 Global Insulin Revenue by Company (2020-2025)
3.2.2 Global Insulin Revenue Market Share by Company (2020-2025)
3.3 Global Insulin Sale Price by Company
3.4 Key Manufacturers Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insulin Product Location Distribution
3.4.2 Players Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Insulin by Geographic Region
4.1 World Historic Insulin Market Size by Geographic Region (2020-2025)
4.1.1 Global Insulin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Insulin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Insulin Market Size by Country/Region (2020-2025)
4.2.1 Global Insulin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Insulin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Insulin Sales Growth
4.4 APAC Insulin Sales Growth
4.5 Europe Insulin Sales Growth
4.6 Middle East & Africa Insulin Sales Growth
5 Americas
5.1 Americas Insulin Sales by Country
5.1.1 Americas Insulin Sales by Country (2020-2025)
5.1.2 Americas Insulin Revenue by Country (2020-2025)
5.2 Americas Insulin Sales by Type (2020-2025)
5.3 Americas Insulin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insulin Sales by Region
6.1.1 APAC Insulin Sales by Region (2020-2025)
6.1.2 APAC Insulin Revenue by Region (2020-2025)
6.2 APAC Insulin Sales by Type (2020-2025)
6.3 APAC Insulin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Insulin by Country
7.1.1 Europe Insulin Sales by Country (2020-2025)
7.1.2 Europe Insulin Revenue by Country (2020-2025)
7.2 Europe Insulin Sales by Type (2020-2025)
7.3 Europe Insulin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insulin by Country
8.1.1 Middle East & Africa Insulin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Insulin Revenue by Country (2020-2025)
8.2 Middle East & Africa Insulin Sales by Type (2020-2025)
8.3 Middle East & Africa Insulin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insulin
10.3 Manufacturing Process Analysis of Insulin
10.4 Industry Chain Structure of Insulin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Insulin Distributors
11.3 Insulin Customer
12 World Forecast Review for Insulin by Geographic Region
12.1 Global Insulin Market Size Forecast by Region
12.1.1 Global Insulin Forecast by Region (2026-2031)
12.1.2 Global Insulin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Insulin Forecast by Type (2026-2031)
12.7 Global Insulin Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Insulin Product Portfolios and Specifications
13.2.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 Sanofi-Aventis
13.3.1 Sanofi-Aventis Company Information
13.3.2 Sanofi-Aventis Insulin Product Portfolios and Specifications
13.3.3 Sanofi-Aventis Insulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi-Aventis Main Business Overview
13.3.5 Sanofi-Aventis Latest Developments
13.4 Tonghua Dongbao
13.4.1 Tonghua Dongbao Company Information
13.4.2 Tonghua Dongbao Insulin Product Portfolios and Specifications
13.4.3 Tonghua Dongbao Insulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Tonghua Dongbao Main Business Overview
13.4.5 Tonghua Dongbao Latest Developments
13.5 Ganlee
13.5.1 Ganlee Company Information
13.5.2 Ganlee Insulin Product Portfolios and Specifications
13.5.3 Ganlee Insulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ganlee Main Business Overview
13.5.5 Ganlee Latest Developments
13.6 United Laboratory
13.6.1 United Laboratory Company Information
13.6.2 United Laboratory Insulin Product Portfolios and Specifications
13.6.3 United Laboratory Insulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 United Laboratory Main Business Overview
13.6.5 United Laboratory Latest Developments
13.7 Jiangsu Wanbang
13.7.1 Jiangsu Wanbang Company Information
13.7.2 Jiangsu Wanbang Insulin Product Portfolios and Specifications
13.7.3 Jiangsu Wanbang Insulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Jiangsu Wanbang Main Business Overview
13.7.5 Jiangsu Wanbang Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂